Table 4.
CD44/FKBPL ratio (>143.6) at 20 weeks gestation is an independent risk factor for developing preeclampsia
| CD44/FKBPL ratio at 20 weeks gestation | Controls | Cases | OR (95% CI) | P-value |
|---|---|---|---|---|
| CD44/FKBPL ratio < 143.6 | 28 (51) | 16 (30) | 1.0a | |
| CD44/FKBPL ratio > 143.6 | 27 (49) | 38 (70) | 2.32 (1.03-5.23) | 0.043 |
| Clinical characteristics | ||||
| BMI (kg/m2) | 25.78 ± 4.01 | 26.93 ± 5.03 | 1.01 (0.91-1.10) | 0.900 |
| Age (years) | 30.14 ± 3.58 | 30.18 ± 4.16 | 0.98 (0.87-1.09) | 0.649 |
| Weight change (kg) | 3.19 ± 1.92 | 2.87 ± 2.00 | 0.90 (0.74-1.10) | 0.319 |
| MAP (mmHg) | 80.13 ± 7.10 | 84.13 ± 8.01 | 0.97 (0.91-1.03) | 0.334 |
CD44/FKBPL ratios are given as n (%) for both cases and controls. All clinical characteristics are given as mean ± SD for both cases and controls.
Abbreviations: BMI, body mass index; CI, confidence interval, MAP, mean arterial pressure; OR, odds ratio.
aReference category.